Back to results
CompletedPhase 3

Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder

NCT00252356

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Sanofi-Aventis Administrative Office

Bridgewater, New Jersey, United States

+1 additional location

View on ClinicalTrials.gov
Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder — TrialFind